Author

J. J. Credle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:genome assembly· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

H. B. Larman· 2 shared J. Gunn· 2 shared A. A. R. Tobian· 1 shared A. L. Cox· 1 shared A. L. Mammen· 1 shared A. L. Tchir· 1 shared A. N. Baer· 1 shared A. Pekosz· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. B. Larman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly

J. J. Credle, J. Gunn, P. Sangkhapreecha, D. R. Monaco, X. A. Zheng, H.-J. Tsai, A. Wilbon, W. R. Morgenlander, Y. Dong, S. Jayaraman, L. Tosi, B. Parekkadan, A. N. Baer, M. Roederer, E. M. Bloch, , H. B. Larman

MIPSA identifies neutralizing IFNL3 autoantibodies in severe COVID-19 patients by profiling autoantibodies against DNA-barcoded proteins.

bioRxiv · Mar 2, 2021 · PreprintImmunology

Highly multiplexed oligonucleotide probe-ligation testing enables efficient extraction-free SARS-CoV-2 detection and viral genotyping

J. J. Credle, M. Robinson, J. Gunn, D. Monaco, B. Sie, A. L. Tchir, J. Hardick, X. Zheng, K. Shaw-Saliba, R. Rothman, S. Eshleman, A. Pekosz, K. Hansen, H. Mostafa, M. Steinegger, H. B. Larman

This paper introduces cRASL-seq, a method for sensitive and high-throughput SARS-CoV-2 detection and genotyping without nucleic acid extraction or reverse transcription.

bioRxiv · Jun 3, 2020Pathology